ReWalk Robotics, Marlborough, Massachusetts, asked the Centers for Medicare & Medicaid Services (CMS) to classify the ReWalk Personal Prosthetic Exoskeleton as artificial legs, which would make it easier for patients to receive its products.
The company presented before CMS at its Healthcare Common Procedure Coding System (HCPCS) meeting in June, detailing why CMS should assign the device to the artificial leg prosthetic benefit category.
“Our collaborative efforts with CMS and other bodies on reimbursement, combined with ongoing improvements of the technology, are driving significant progress against this goal. Further, recent public sessions and subsequent interaction with CMS are encouraging steps on this pathway to deliver for patients and create value for our shareholders. We look forward to near-term milestones that have the potential to significantly catalyze our growth via expanded reimbursement,” said ReWalk CEO Larry Jasinski.
ReWalk said it expects feedback about the request from CMS later this year.
